Nek6 overexpression antagonizes p53-induced senescence in human cancer cells

Cell Cycle

Volumn 9, Issue 23, 2010, Pages 4703-4710

  Jee, Hye Jin ^a   Kim, Ae Jeong ^a   Song, Naree ^a   Kim, Hyun Ju ^a   Kim, Minjee ^a   Koh, Hyongjong ^a   Yun, Jeanho ^a  

^a Dong A University   (South Korea)

Author keywords

Cell cycle; Cellular senescence; Nek6; p53; Tumorigenesis

Indexed keywords

BETA GALACTOSIDASE; COMPLEMENTARY DNA; CYCLIN B; DNA; NEK6 PROTEIN KINASE; NIMA RELATED KINASE; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; REACTIVE OXYGEN METABOLITE; RNA; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER CELL; CELL AGING; CELL CYCLE; CONTROLLED STUDY; DNA DAMAGE; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

EID: 78650080431     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.23.14059     Document Type: Article

References (27)

1. Campisi J, d'Adda di Fagagna F. Cellular senescence: When bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8:729-40.
2. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92:9363-7.
3. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005; 37:961-76. (Pubitemid 40311739)
4. Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L, et al. Restoration of p53 function leads to tumor regression in vivo. Nature 2007; 445:661-5. (Pubitemid 46232887)
5. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, et al. Senescence and tumor clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445:656-60. (Pubitemid 46232886)
6. O'Regan L, Blot J, Fry AM. Mitotic regulation by NIMA-related kinases. Cell Div 2007; 2:25.
7. Belham C, Roig J, Caldwell JA, Aoyama Y, Kemp BE, Comb M, et al. A mitotic cascade of NIMA family kinases. Nercc1/Nek9 activates the Nek6 and Nek7 kinases. J Biol Chem 2003; 278:34897-909. (Pubitemid 37102249)
8. Yin MJ, Shao L, Voehringer D, Smeal T, Jallal B. The serine/threonine kinase Nek6 is required for cell cycle progression through mitosis. J Biol Chem 2003; 278:52454-60. (Pubitemid 38035838)
9. 2/M phase cell cycle arrest through DNA damage-induced phosphorylation. Cell Cycle 2008; 7:2705-9.
10. Hashimoto Y, Akita H, Hibino M, Kohri K, Nakanishi M. Identification and characterization of Nek6 protein kinase, a potential human homolog of NIMA histone H3 kinase. Biochem Biophys Res Commun 2002; 293:753-8. (Pubitemid 34687252)
11. Li MZ, Yu L, Liu Q, Chu JY, Zhao SY. Assignment of NEK6, a NIMA-related gene, to human chromosome 9q33. 3→q34.11 by radiation hybrid mapping. Cytogenet Cell Genet 1999; 87:271-2.
12. Chen J, Li L, Zhang Y, Yang H, Wei Y, Zhang L, et al. Interaction of Pin1 with Nek6 and characterization of their expression correlation in Chinese hepatocellular carcinoma patients. Biochem Biophys Res Commun 2006; 341:1059-65. (Pubitemid 43221773)
13. Takeno A, Takemasa I, Doki Y, Yamasaki M, Miyata H, Takiguchi S, et al. Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis. Br J Cancer 2008; 99:1307-15.
14. Nassirpour R, Shao L, Flanagan P, Abrams T, Jallal B, Smeal T, et al. Nek6 mediates human cancer cell transformation and is a potential cancer therapeutic target. Mol Cancer Res 2010; 8:717-28.
15. L and E1B-19K proteins inhibit p53-induced irreversible growth arrest and senescence by preventing reactive oxygen species-dependent p38 activation. J Biol Chem 2004; 279:17765-71.
16. Jung MS, Yun J, Chae HD, Kim JM, Kim SC, Choi TS, et al. p53 and its homologs, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor. Oncogene 2001; 20:5818-25. (Pubitemid 32937951)
17. Sugrue MM, Shin DY, Lee SW, Aaronson SA. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc Natl Acad Sci USA 1997; 94:9648-53. (Pubitemid 27408116)
18. Wang Y, Blandino G, Oren M, Givol D. Induced p53 expression in lung cancer cell line promotes cell senescence and differentially modifies the cytotoxicity of anti-cancer drugs. Oncogene 1998; 17:1923-30. (Pubitemid 28488460)
19. Jeon YJ, Lee KY, Cho YY, Pugliese A, Kim HG, Jeong CH, et al. The role of NEK6 in tumor promoter-induced transformation in JB6 C141 mouse skin epidermal cells. J Biol Chem 2010; 285:28126-33.
20. 2 checkpoint through cyclin B1. Proc Natl Acad Sci USA 1999; 96:2147-52.
21. 2-M arrest. Cancer Res 2000; 60:542-5.
22. Demidenko ZN, Korotchkina LG, Gudkov AV, Blagosklonny MV. Paradoxical suppression of cellular senescence by p53. Proc Natl Acad Sci USA 2010; 107:9660-4.
23. Korotchkina LG, Leontieva OV, Bukreeva EI, Demidenko ZN, Gudkov AV, Blagosklonny MV. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging (Albany NY) 2010; 2:344-52.
24. Poyurovsky MV, Prives C. p53 and aging: A fresh look at an old paradigm. Aging (Albany NY) 2010; 2:380-2.
25. Vigneron A, Vousden KH. p53, ROS and senescence in the control of aging. Aging (Albany NY) 2010; 2:471-4.
26. Belham C, Comb MJ, Avruch J. Identification of the NIMA family kinases NEK6/7 as regulators of the p70 ribosomal S6 kinase. Curr Biol 2001; 11:1155-67. (Pubitemid 32722568)
27. Kim MA, Kim HJ, Brown AL, Lee MY, Bae YS, Park JI, et al. Identification of novel substrates for human checkpoint kinase Chk1 and Chk2 through genome-wide screening using a consensus Chk phosphorylation motif. Exp Mol Med 2007; 39:205-12. (Pubitemid 46683406)